MOLN:SWX
Molecular Partners AG
CHF 3.06
arrow_downward
-1.29%(-0.040) 1D
Oct 19, 5:31:13 PM GMT+2 · CHF
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MOLN...
Open
CHF 3.07
High
CHF 3.14
Low
CHF 3.04
Mkt. cap
123.55M
Avg. vol.
10.48K
Volume
17.87K
52-wk high
CHF 3.96
52-wk low
CHF 2.66
EPS
-CHF 1.37
Shares outstanding
40.37M
No. of employees
134
Open
CHF 3.07
High
CHF 3.14
Low
CHF 3.04
Mkt. cap
123.55M
Avg. vol.
10.48K
Volume
17.87K
52-wk high
CHF 3.96
52-wk low
CHF 2.66
EPS
-CHF 1.37
Shares outstanding
40.37M
No. of employees
134
News stories
From web sources and news partners
Trefis
·
28 minutes ago
S&P 500 Movers | Winners: WDC, SNDK, DDOG | Losers: MOS, NRG, AMP
Stocktwits
·
1 hour ago
Dow, S&P 500, Nasdaq Edge Higher Amid Tech Rebound As Q3 Earnings Season Forges Ahead: DJT, AMZN, CBRS, CRWV Stocks In Focus
Investing.com
·
8 hours ago
U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.07%
Profile
Molecular Partners AG is a clinical-stage biopharmaceutical company based in Zürich, Switzerland. The company is developing a new class of potent, specific and versatile small-protein therapies called DARPins, with potential clinical applications in a range of disease areas including oncology, immuno-oncology, ophthalmology, and infectious diseases. Molecular Partners currently has two DARPin molecules in clinical development, and a broad pipeline of molecules in preclinical development. Wikipedia
About Molecular Partners AG